Associations between environmental exposures and incident colorectal cancer by ESR2 protein expression level in a population-based cohort of older women

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 4, 2015, Pages 713-719

  Tillmans, Lori S ^a   Vierkant, Robert A ^a   Wang, Alice H ^a   Samadder, Niloy Jewel ^b   Lynch, Charles F ^c   Anderson, Kristin E ^d   French, Amy J ^a   Haile, Robert W ^e   Harnack, Lisa J ^d   Potter, John D ^f   Slager, Susan L ^a   Smyrk, Thomas C ^a   Thibodeau, Stephen N ^a   Cerhan, James R ^a   Limburg, Paul J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e STANFORD CANCER INSTITUTE   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESR2 PROTEIN; ESTROGEN RECEPTOR BETA; FOLIC ACID; UNCLASSIFIED DRUG; ESR2 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COLON CARCINOGENESIS; COLORECTAL CANCER; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; EXPOSURE VARIABLE; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OUTCOME VARIABLE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SMOKING; TISSUE MICROARRAY; ADVERSE EFFECTS; AGED; COLORECTAL NEOPLASMS; HORMONE SUBSTITUTION; IMMUNOHISTOCHEMISTRY; INCIDENCE; METABOLISM; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR;

AGED; COLORECTAL NEOPLASMS; ENVIRONMENTAL EXPOSURE; ESTROGEN RECEPTOR BETA; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SURVEYS AND QUESTIONNAIRES;

EID: 84927938690     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0756     Document Type: Article

References (47)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
2. Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst 2010;102:1012-22.
3. Samadder NJ, Vierkant RA, Tillmans LS, Wang AH, Lynch CF, Anderson KE, et al. Cigarette smoking and colorectal cancer risk by KRAS mutation status among older women. Am J Gastroenterol 2012;107:782-9.
4. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: ameta-analysis. JAMA 2008;300:2765-78.
5. Slattery ML, Anderson K, Samowitz W, Edwards SL, Curtin K, Caan B, et al. Hormone replacement therapy and improved survival among postmenopausal women diagnosedwith colon cancer (USA). Cancer Causes Control 1999;10:467-73.
6. Mandelson MT, Miglioretti D, Newcomb PA, Harrison R, Potter JD. Hormone replacement therapy in relation to survival in women diagnosed with colon cancer. Cancer Causes Control 2003;14:979-84.
7. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 1980;65:1201-7.
8. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350:991-1004.
9. Sanderson P, Stone E, Kim YI, Mathers JC, Kampman E, Downes CS, et al. Folate and colo-rectal cancer risk. Br J Nutr 2007;98:1299-304.
10. Kim DH, Smith-Warner SA, Spiegelman D, Yaun SS, Colditz GA, Freudenheim JL, et al. Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control 2010;21: 1919-30.
11. Carroll C, Cooper K, Papaioannou D, Hind D, Tappenden P, Pilgrim H, et al. Meta-analysis: folic acid in the chemoprevention of colorectal adenomas and colorectal cancer. Aliment Pharmacol Ther 2010;31: 708-18.
12. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010;138:2088-100.
13. Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn 2008;10:13-27.
14. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50:113-30.
15. Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, et al. Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women. Gut 2012;61: 1299-305.
16. Limburg PJ, Limsui D, Vierkant RA, Tillmans LS, Wang AH, Lynch CF, et al. Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women. Cancer Epidemiol Biomarkers Prev 2012;21:681-4.
17. Samowitz WS, Albertsen H, Sweeney C, Herrick J, Caan BJ, Anderson KE, et al. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 2006;98: 1731-8.
18. Razzak AA, Oxentenko AS, Vierkant RA, Tillmans LS, Wang AH, Weisienberger DJ, et al. Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study. Nutr Cancer 2012;64:899-910.
19. Tillmans LS, Vierkant RA, Wang AH, Samadder NJ, Lynch CF, Anderson KE, et al. Associations between Cigarette Smoking, Hormone Therapy, and Folate Intake with Incident Colorectal Cancer by TP53 Protein Expression Level in a Population-Based Cohort of Older Women. Cancer Epidemiol Biomarkers Prev 2014;23:350-5.
20. Rudolph A, Toth C, Hoffmeister M, Roth W, Herpel, Schirmacher P, et al. Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor-beta. Cancer Res 2013;73:3306-15.
21. Principi M, Di Leo A, Pricci M, Scavo MP, Guido R, Tanzi S, et al. Phytoestrogens/insoluble fibers and colonic estrogen receptor beta: randomized, double-blind, placebo-controlled study. World J Gastroenterol 2013;19:4325-33.
22. Witte D, Chirala M, Younes A, Li Y, Younes M. Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Hum Pathol 2001;32: 940-4.
23. Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 2008; 9:385-91.
24. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003;39: 1251-8.
25. Caiazza F, Galluzzo P, Lorenzetti S, Marino M. 17Beta-estradiol induces ERbeta up-regulation via p38/MAPK activation in colon cancer cells. Biochem Biophys Res Commun 2007;359:102-7.
26. Rudolph A, Toth C, Hoffmeister M, Roth W, Herpel E, Jansen L, et al. Expression of oestrogen receptor beta and prognosis of colorectal cancer. Br J Cancer 2012;107:831-9.
27. Peng J, Xu X, Mace BE, Vanderveer LA, Workman LR, Slifker MJ, et al. Estrogen metabolism within the lung and its modulation by tobacco smoke. Carcinogenesis 2013;34:909-15.
28. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausalwomen.AmJ Epidemiol 1990;131:794-803.
29. Willett WC, Sampson L, Browne ML, Stampfer MJ, Rosner B, Hennekens CH, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988;127:188-99.
30. Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999;8:1117-21.
31. Cheng X, Chen VW, Steele B, Ruiz B, Fulton J, Liu L, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer 2001;92:2547-54.
32. Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer 1999;85:1670-6.
33. Lee JE, Baba Y, Ng K, Giovannucci E, Fuchs CS, Ogino S, et al. Statin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies. Cancer Prev Res 2011;4:1808-15.
34. Schernhammer ES, Giovannucci E, Baba Y, Fuchs CS, Ogino S. B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP). PLoS ONE 2011;6:e21102.
35. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-81.
36. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
37. Lunn M,McNeil D. Applying Cox regression to competing risks. Biometrics 1995;51:524-32.
38. Kanthan R, Senger JL, Kanthan SC. Molecular events in primary and metastatic colorectal carcinoma: a review. Pathol Res Int 2012;2012: 597497.
39. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, Edwards S, et al. Associations between cigarette smoking, lifestyle factors, andmicrosatellite instability in colon tumors. J Natl Cancer Inst 2000;92:1831-6.
40. Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD. Risk factors for hyperplastic and adenomatous polyps: evidence for the malignant potential? Cancer Epidemiol Biomarkers Prev 2002;11:1012-8.
41. Burnett-Hartman AN, Passarelli MN, Adams SV, UptonMP, Zhu LC, Potter JD, et al. Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol 2013;177:625-37.
42. Cleary SP, Cotterchio M, Shi E, Gallinger S, Harper P. Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk. Am J Epidemiol 2010;172:1000-14.
43. Skliris GP, Parkes AT, Limer JL, Burdall SE,Carder PJ, Speirs V. Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue. J Pathol 2002;197:155-62.
44. Xie LQ, Yu JP, Luo HS. Expression of estrogen receptor beta in human colorectal cancer. World J Gastroenterol 2004;10:214-7.
45. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, et al. Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J Cell Physiol 2005;203:193-201.
46. MarinoM, Ascenzi P.Membrane association of estrogen receptor alpha and beta influences 17beta-estradiol-mediated cancer cell proliferation. Steroids 2008;73:853-8.
47. Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathology epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011;60:397-411.